Pages that link to "Q241374"
Jump to navigation
Jump to search
The following pages link to ursodiol (Q241374):
Displaying 50 items.
- chenodiol (Q419028) (← links)
- primary biliary cholangitis (Q1072420) (← links)
- cholelithiasis (Q7069348) (← links)
- Ursa (Q21059664) (← links)
- Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis (Q26778511) (← links)
- Network meta-analysis of randomized controlled trials: efficacy and safety of UDCA-based therapies in primary biliary cirrhosis (Q26824664) (← links)
- The role of ursodeoxycholic acid in non-alcoholic steatohepatitis: a systematic review (Q26825269) (← links)
- Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis (Q27023986) (← links)
- isoursodeoxycholic acid (Q27104506) (← links)
- 3beta,7alpha-dihydroxy-5beta-cholan-24-oic acid (Q27105124) (← links)
- Allochenodeoxycholate (Q27155199) (← links)
- (4R)-4-[(3R,5S,7R,8S,9R,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid (Q27166426) (← links)
- (4R)-4-[(3R,5S,7S,8S,9R,10S,13R,14S,17S)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid (Q27166491) (← links)
- Optimal drug regimens for primary biliary cirrhosis: a systematic review and network meta-analysis (Q28087211) (← links)
- Combination therapy of ursodeoxycholic acid and budesonide for PBC-AIH overlap syndrome: a meta-analysis (Q35006396) (← links)
- The use of ursodeoxycholic acid in patients with primary biliary cirrhosis: sense or nonsense. (Q35677715) (← links)
- Molecular mechanisms of ursodeoxycholic acid toxicity & side effects: ursodeoxycholic acid freezes regeneration & induces hibernation mode. (Q36197335) (← links)
- Game and players: mitochondrial apoptosis and the therapeutic potential of ursodeoxycholic acid. (Q36815849) (← links)
- Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study). (Q37328837) (← links)
- Bile acid supplementation improves established liver steatosis in obese mice independently of glucagon-like peptide-1 secretion (Q38307168) (← links)
- Comparative studies of bile salts. 7. Bile acids of the coypu, Myocastor coypus (Q39240165) (← links)
- The overlap syndrome of autoimmune hepatitis and primary biliary cirrhosis. Clinical and therapeutic analysis of 5 cases (Q44611426) (← links)
- Actigall (Q47520960) (← links)
- Urso (Q47522256) (← links)
- Primary biliary cholangitis : therapeutic and evolving aspects about 46 cases (Q57498639) (← links)
- Ursodeoxycholic Acid (UDCA) for Hepatic Sarcoidosis (Q61907516) (← links)
- Ursodiol in Treating Patients With Barrett Esophagus and Low-Grade Dysplasia (Q61936448) (← links)
- Effects of Ursodeoxycholic Acid on Graft Recovery Early After Adult Liver Transplantation (Q61938480) (← links)
- Ursofalk Tablets (500 mg) Versus Ursofalk Capsules (250 mg) in the Treatment of Primary Biliary Cirrhosis (Q61956123) (← links)
- Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis (Q61966055) (← links)
- The Preventative and Therapeutical Effect of Ursodeoxycholic Acid(UDCA) to Short Bowel Syndrome Patients (Q61975046) (← links)
- Clinical Studies on Bile Acids in Barrett's Esophagus (Q61981256) (← links)
- Therapeutic And Dietary Effects Of The Sublimated Mare's Milk Supplement In Patients With Non-Alcoholic Steatohepatitis (Q62062057) (← links)
- Impact of Ursodeoxycholic Acid, Silymarin, Antioxidants and Colchicine on Fibrosis Regression in HCV After SVR (Q62062490) (← links)
- Non-comparative Study of BCD-085 in Combination With UDCA in Patients With Primary Biliary Cholangitis (Q62813224) (← links)
- Umbilical Cord Mesenchymal Stem Cells in Primary Sclerosing Cholangitis (Q62817999) (← links)
- A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fed Conditions (Q62819581) (← links)
- A Single-dose, Comparative Bioavailability Study of Two Formulations of Ursodiol 500mg Tablets Under Fasting Conditions (Q62819588) (← links)
- Study to Assess Safety and Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid. (Q63013706) (← links)
- Ursodeoxycholic Acid Plus Budesonide Versus Ursodeoxycholic Acid Alone in Primary Biliary Cirrhosis (PBC) (Q63062107) (← links)
- Ursodeoxycholic Acid in the Treatment of Intrahepatic Cholestasis of Pregnancy (Q63315687) (← links)
- Ursodeoxycholic Acid in Bariatric Surgery (Q63316481) (← links)
- Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis (Q63322532) (← links)
- Efficacy and Safety of Ursodeoxycholic Acid (UDCA) Added to the DPP-4 Inhibitor in People With Type 2 Diabetes and Chronic Liver Diseases (Q63335603) (← links)
- Clinical Trial on the Effect of the Sublimated Mare Milk Supplement on Primary Biliary Cholangitis (Q63393566) (← links)
- Curative Effect Observation of UDCA Combined Probiotics Therapy in PBC of Poor Response to UDCA (Q63397393) (← links)
- (4R)-4-[(3S,5R,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid (Q63399411) (← links)
- (4R)-4-[(3R,5R,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid (Q63399414) (← links)
- (4R)-4-[(3S,5R,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid (Q63399415) (← links)
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis (Q63404008) (← links)